TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
11 2021
Historique:
received: 16 07 2021
accepted: 09 11 2021
revised: 06 12 2021
pubmed: 23 11 2021
medline: 24 12 2021
entrez: 22 11 2021
Statut: epublish

Résumé

Interferons play a critical role in regulating host immune responses to SARS-CoV-2, but the interferon (IFN)-stimulated gene (ISG) effectors that inhibit SARS-CoV-2 are not well characterized. The IFN-inducible short isoform of human nuclear receptor coactivator 7 (NCOA7) inhibits endocytic virus entry, interacts with the vacuolar ATPase, and promotes endo-lysosomal vesicle acidification and lysosomal protease activity. Here, we used ectopic expression and gene knockout to demonstrate that NCOA7 inhibits infection by SARS-CoV-2 as well as by lentivirus particles pseudotyped with SARS-CoV-2 Spike in lung epithelial cells. Infection with the highly pathogenic, SARS-CoV-1 and MERS-CoV, or seasonal, HCoV-229E and HCoV-NL63, coronavirus Spike-pseudotyped viruses was also inhibited by NCOA7. Importantly, either overexpression of TMPRSS2, which promotes plasma membrane fusion versus endosomal fusion of SARS-CoV-2, or removal of Spike's polybasic furin cleavage site rendered SARS-CoV-2 less sensitive to NCOA7 restriction. Collectively, our data indicate that furin cleavage sensitizes SARS-CoV-2 Spike to the antiviral consequences of endosomal acidification by NCOA7, and suggest that the acquisition of furin cleavage may have favoured the co-option of cell surface TMPRSS proteases as a strategy to evade the suppressive effects of IFN-induced endo-lysosomal dysregulation on virus infection.

Identifiants

pubmed: 34807954
doi: 10.1371/journal.ppat.1009820
pii: PPATHOGENS-D-21-01487
pmc: PMC8648102
doi:

Substances chimiques

NCOA7 protein, human 0
Nuclear Receptor Coactivators 0
Protein Isoforms 0
Spike Glycoprotein, Coronavirus 0
Interferons 9008-11-1
Serine Endopeptidases EC 3.4.21.-
TMPRSS2 protein, human EC 3.4.21.-
FURIN protein, human EC 3.4.21.75
Furin EC 3.4.21.75

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009820

Subventions

Organisme : Wellcome Trust
ID : 106223/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 207442/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15068
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/10
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W005611/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201366/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : U54 AI150472
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Virol. 2015 Jul;89(14):7202-13
pubmed: 25926653
Nat Commun. 2020 Sep 11;11(1):4541
pubmed: 32917884
J Virol. 2006 Feb;80(4):2013-8
pubmed: 16439557
Science. 2021 Jan 15;371(6526):288-292
pubmed: 33293339
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
J Mol Histol. 2020 Dec;51(6):613-628
pubmed: 33011887
N Engl J Med. 2003 May 15;348(20):1977-85
pubmed: 12671062
Clin Transl Immunology. 2019 Aug 05;8(8):e1073
pubmed: 31406574
Autophagy. 2015;11(8):1437-8
pubmed: 26156798
Cell. 2020 Dec 10;183(6):1520-1535.e14
pubmed: 33157038
Cell Discov. 2020 Nov 4;6(1):80
pubmed: 33298900
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
PLoS Pathog. 2020 Jul 29;16(7):e1008737
pubmed: 32726355
Nat Microbiol. 2020 Nov;5(11):1330-1339
pubmed: 32704094
Antiviral Res. 2020 Jul;179:104811
pubmed: 32360182
Elife. 2021 Jan 04;10:
pubmed: 33393462
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Genome Med. 2020 Jul 28;12(1):68
pubmed: 32723359
Cell Res. 2021 Feb;31(2):126-140
pubmed: 33420426
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
BMC Cell Biol. 2007 Mar 28;8:13
pubmed: 17391516
J Virol. 2020 Nov 9;94(23):
pubmed: 32938761
PLoS Pathog. 2021 Jan 25;17(1):e1009246
pubmed: 33493182
PLoS Pathog. 2021 Jan 19;17(1):e1009212
pubmed: 33465165
Cell. 2021 Jan 7;184(1):106-119.e14
pubmed: 33333024
J Virol. 2021 Apr 12;95(9):
pubmed: 33563656
Metabolism. 1997 Sep;46(9):1090-4
pubmed: 9284902
Nature. 2021 Mar;591(7849):293-299
pubmed: 33494095
PLoS One. 2013;8(1):e54290
pubmed: 23335997
Cell. 1998 Oct 30;95(3):409-17
pubmed: 9814710
Elife. 2021 Apr 09;10:
pubmed: 33835028
Immunity. 2021 Jun 8;54(6):1276-1289.e6
pubmed: 33836142
Emerg Infect Dis. 2005 Mar;11(3):411-6
pubmed: 15757556
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Adv Virus Res. 2018;100:163-188
pubmed: 29551135
Sci Rep. 2019 Jun 18;9(1):8682
pubmed: 31213630
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
EMBO J. 2021 Aug 2;40(15):e107826
pubmed: 34101213
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93
pubmed: 15897467
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Nat Microbiol. 2018 Dec;3(12):1369-1376
pubmed: 30478388
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6
pubmed: 19321428
Epidemiol Infect. 1990 Oct;105(2):435-46
pubmed: 2170159
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
J Virol. 2009 Aug;83(15):7411-21
pubmed: 19439480
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
EMBO J. 2021 Feb 1;40(3):e106501
pubmed: 33270927
Cell. 2021 Jan 7;184(1):92-105.e16
pubmed: 33147445
J Virol. 1994 Feb;68(2):1213-8
pubmed: 8289354
Lancet. 2021 Feb 6;397(10273):452-455
pubmed: 33515491
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4526-9
pubmed: 3380803
Emerg Microbes Infect. 2020 Dec;9(1):837-842
pubmed: 32301390
Nat Struct Mol Biol. 2020 Aug;27(8):763-767
pubmed: 32647346
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Rev Med Virol. 2015 Nov;25(6):406-30
pubmed: 26467906
J Virol. 2018 Jul 17;92(15):
pubmed: 29769339
Nat Microbiol. 2021 Jul;6(7):899-909
pubmed: 33907312
Cell Rep. 2021 Jul 13;36(2):109364
pubmed: 34214467
Mol Cell Biol. 2002 May;22(10):3358-72
pubmed: 11971969
J Virol. 2021 Jan 29;:
pubmed: 33514628
Antiviral Res. 2020 Apr;176:104742
pubmed: 32057769
J Virol. 2012 Mar;86(5):2706-14
pubmed: 22205751
J Virol. 2000 Oct;74(19):9234-9
pubmed: 10982370
J Interferon Cytokine Res. 2015 Mar;35(3):186-99
pubmed: 25330068
Sci Rep. 2015 Dec 08;5:17916
pubmed: 26643317
Nat Biotechnol. 1997 Sep;15(9):871-5
pubmed: 9306402
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
N Engl J Med. 2014 Jun 26;370(26):2499-505
pubmed: 24896817
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
Virology. 2018 Apr;517:9-15
pubmed: 29217279
PLoS Biol. 2021 Feb 25;19(2):e3001091
pubmed: 33630831
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9
pubmed: 25288733
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
PLoS One. 2012;7(12):e50859
pubmed: 23227216
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32105-32113
pubmed: 33239446
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
EMBO J. 2020 Dec 1;39(23):e106267
pubmed: 33051876
Science. 2020 Dec 18;370(6523):1464-1468
pubmed: 33184236
Signal Transduct Target Ther. 2020 Jun 12;5(1):92
pubmed: 32532959
J Virol. 2015 Feb;89(3):1851-66
pubmed: 25428868
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
iScience. 2021 Mar 19;24(3):102151
pubmed: 33585804
Life Sci Alliance. 2020 Jul 23;3(9):
pubmed: 32703818
Front Microbiol. 2020 Nov 25;11:593857
pubmed: 33324374

Auteurs

Hataf Khan (H)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Helena Winstone (H)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Jose M Jimenez-Guardeño (JM)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Carl Graham (C)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Katie J Doores (KJ)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Caroline Goujon (C)

IRIM, CNRS, Université de Montpellier, Montpellier, France.

David A Matthews (DA)

School of Cellular and Molecular Medicine, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, United Kingdom.

Andrew D Davidson (AD)

School of Cellular and Molecular Medicine, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, United Kingdom.

Suzannah J Rihn (SJ)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Massimo Palmarini (M)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Stuart J D Neil (SJD)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Michael H Malim (MH)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH